Making NICE nicer
This article was originally published in The Gray Sheet
Executive SummaryUK's National Institute of Clinical Excellence should consider directing the National Health Service to evaluate medical device "effectiveness versus efficacy" in cases where randomized controlled trial data are absent, according to the Association of British Health-Care Industries. "Adherence to the hierarchy of evidence necessarily biases the work of NICE against non-pharmaceutical products," ABHI asserts, noting that device makers are "unlikely to have such large-scale studies," relying instead on "naturalistic study designs such as registries." In January testimony responding to the House of Commons Health Committee's inquiry of NICE, the device trade group urged a more transparent topic selection process and warned of technologies becoming "sidelined" if they are not chosen for NICE appraisal...
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.